635 related articles for article (PubMed ID: 31732509)
21. Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples.
Choi SI; Jeon AR; Kim MK; Lee YS; Im JE; Koh JW; Han SS; Kong SY; Yoon KA; Koh YH; Lee JH; Lee WJ; Park SJ; Hong EK; Woo SM; Kim YH
Front Oncol; 2019; 9():875. PubMed ID: 31572675
[TBL] [Abstract][Full Text] [Related]
22. Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts.
Okano M; Oshi M; Butash A; Okano I; Saito K; Kawaguchi T; Nagahashi M; Kono K; Ohtake T; Takabe K
J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):27-36. PubMed ID: 32109311
[TBL] [Abstract][Full Text] [Related]
23. Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma.
Zhao P; Chen H; Wen D; Mou S; Zhang F; Zheng S
Cancer Commun (Lond); 2018 Aug; 38(1):54. PubMed ID: 30139386
[TBL] [Abstract][Full Text] [Related]
24. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a novel tumorigenic esophageal adenocarcinoma cell line: OANC1.
Clemons NJ; Do H; Fennell C; Deb S; Fellowes A; Dobrovic A; Phillips WA
Dig Dis Sci; 2014 Jan; 59(1):78-88. PubMed ID: 24077944
[TBL] [Abstract][Full Text] [Related]
26. High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
Igarashi K; Kawaguchi K; Murakami T; Kiyuna T; Miyake K; Singh AS; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
J Cell Biochem; 2017 Sep; 118(9):2739-2743. PubMed ID: 28176365
[TBL] [Abstract][Full Text] [Related]
27. A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model.
Lim HI; Yamamoto J; Inubushi S; Nishino H; Tashiro Y; Sugisawa N; Han Q; Sun YU; Choi HJ; Nam SJ; Kim MB; Lee JS; Hozumi C; Bouvet M; Singh SR; Hoffman RM
Anticancer Res; 2020 May; 40(5):2481-2485. PubMed ID: 32366392
[TBL] [Abstract][Full Text] [Related]
28. Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.
Murakami T; Singh AS; Kiyuna T; Dry SM; Li Y; James AW; Igarashi K; Kawaguchi K; DeLong JC; Zhang Y; Hiroshima Y; Russell T; Eckardt MA; Yanagawa J; Federman N; Matsuyama R; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
Oncotarget; 2016 Jul; 7(30):47556-47564. PubMed ID: 27286459
[TBL] [Abstract][Full Text] [Related]
29. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
[TBL] [Abstract][Full Text] [Related]
30. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology.
Golebiewska A; Hau AC; Oudin A; Stieber D; Yabo YA; Baus V; Barthelemy V; Klein E; Bougnaud S; Keunen O; Wantz M; Michelucci A; Neirinckx V; Muller A; Kaoma T; Nazarov PV; Azuaje F; De Falco A; Flies B; Richart L; Poovathingal S; Arns T; Grzyb K; Mock A; Herold-Mende C; Steino A; Brown D; May P; Miletic H; Malta TM; Noushmehr H; Kwon YJ; Jahn W; Klink B; Tanner G; Stead LF; Mittelbronn M; Skupin A; Hertel F; Bjerkvig R; Niclou SP
Acta Neuropathol; 2020 Dec; 140(6):919-949. PubMed ID: 33009951
[TBL] [Abstract][Full Text] [Related]
31. Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern.
Hiroshima Y; Zhang Y; Zhang N; Maawy A; Mii S; Yamamoto M; Uehara F; Miwa S; Yano S; Murakami T; Momiyama M; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Murata T; Endo I; Hoffman RM
PLoS One; 2015; 10(2):e0117417. PubMed ID: 25689852
[TBL] [Abstract][Full Text] [Related]
32. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS
PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237
[TBL] [Abstract][Full Text] [Related]
33. Genetic and metabolic comparison of orthotopic and heterotopic patient-derived pancreatic-cancer xenografts to the original patient tumors.
Jun E; Hong SM; Yoo HJ; Kim MB; Won JS; An S; Shim IK; Chang S; Hoffman RM; Kim SC
Oncotarget; 2018 Jan; 9(8):7867-7881. PubMed ID: 29487698
[TBL] [Abstract][Full Text] [Related]
34. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
[TBL] [Abstract][Full Text] [Related]
35. Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models.
Zhang H; Du Y; Qi L; Xiao S; Braun FK; Kogiso M; Huang Y; Huang F; Abdallah A; Suarez M; Karthick S; Ahmed NM; Salsman VS; Baxter PA; Su JM; Brat DJ; Hellenbeck PL; Teo WY; Patel AJ; Li XN
J Transl Med; 2023 Jul; 21(1):444. PubMed ID: 37415222
[TBL] [Abstract][Full Text] [Related]
36. Translational pancreatic cancer research: A comparative study on patient-derived xenograft models.
Rubio-Manzanares Dorado M; Marín Gómez LM; Aparicio Sánchez D; Pereira Arenas S; Praena-Fernández JM; Borrero Martín JJ; Farfán López F; Gómez Bravo MÁ; Muntané Relat J; Padillo Ruiz J
World J Gastroenterol; 2018 Feb; 24(7):794-809. PubMed ID: 29467550
[TBL] [Abstract][Full Text] [Related]
37. A Case of Rare Matrix-producing Triple-negative Breast Carcinoma for Which Drug Response in a Patient-derived Orthotopic Xenograft Mouse Model Was Correlated With Patient Response.
Nomura T; Kurebayashi J; Moriya T; Saito W; Murata T; Yamamoto J; Hozumi C; Hoffman RM
Anticancer Res; 2021 Dec; 41(12):6191-6197. PubMed ID: 34848473
[TBL] [Abstract][Full Text] [Related]
38. Imaging the microenvironment of pancreatic cancer patient-derived orthotopic xenografts (PDOX) growing in transgenic nude mice expressing GFP, RFP, or CFP.
Hoffman RM; Bouvet M
Cancer Lett; 2016 Sep; 380(1):349-55. PubMed ID: 26742463
[TBL] [Abstract][Full Text] [Related]
39. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract][Full Text] [Related]
40. Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model.
Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Miyake K; Miyake M; Li Y; Nelson SD; Dry SM; Singh AS; Russell TA; Singh SR; Kanaya F; Eilber FC; Hoffman RM
Tissue Cell; 2018 Aug; 53():30-36. PubMed ID: 30060824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]